Ferit Kuscu

Adana, TR 
Adana, TR 

Overview

Ferit Kuscu practices practicing medicine in Adana, Turkey.

Their clinical expertise encompasses HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Hepatitis, and Syphilis.

They are actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 2 clinical trials.

Locations

Adana, 01330, Turkey
Other Locations
Cukurova, Turkey
Istanbul, Turkey
Yildirim Beyazit, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

48 Total Publications

Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
Journal: The Journal of international medical research
Published: August 27, 2026

Frequently Asked Questions about Ferit Kuscu

Is Ferit Kuscu a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Ferit Kuscu is classified as an Experienced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ferit Kuscu participate in research or clinical trials?

Yes. Ferit Kuscu has published 48 articles and abstracts on conditions like HIV/AIDS. You can view a list of Ferit Kuscu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kuscu's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile